Reward-specific Changes of the Chemical Messenger Dopamine in the Brain of Healthy and Depressed People

NCT06675851 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Major Depressive Disorder (MDD)

Interventions

DRUG: WELLBUTRIN SR (Bupropion HCI) Sustained-Release Tablets, 150 mg; GlaxoSmithKline
DRUG: Cipralex (escitalopram)

Sponsor

Medical University of Vienna

Collaborators

[object Object]